Genentech review of Tessier-Lavigne paper finds no evidence of fraud — but hints at a different misconduct case
STAT
APRIL 6, 2023
South San Francisco biotech Genentech on Thursday announced that an internal review of misconduct allegations concerning a landmark 2009 paper co-authored by Marc Tessier-Lavigne, a former top executive at the company and Stanford University’s current president, did not find any evidence of fraud or intentional wrongdoing.
Let's personalize your content